| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 23 | 2020 | 9856 | 1.120 |
Why?
|
| Lung Diseases | 5 | 2020 | 1886 | 1.050 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 2022 | 123 | 0.800 |
Why?
|
| Pemphigoid, Bullous | 1 | 2022 | 109 | 0.760 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2019 | 808 | 0.690 |
Why?
|
| Glycogen Storage Disease | 1 | 2018 | 41 | 0.660 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2023 | 944 | 0.650 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2019 | 256 | 0.650 |
Why?
|
| Vital Capacity | 2 | 2019 | 925 | 0.650 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2019 | 57 | 0.620 |
Why?
|
| Respiratory Insufficiency | 5 | 2019 | 1199 | 0.620 |
Why?
|
| Expeditions | 1 | 2017 | 12 | 0.590 |
Why?
|
| Pandemics | 6 | 2023 | 8388 | 0.530 |
Why?
|
| Nerve Growth Factors | 3 | 2013 | 574 | 0.480 |
Why?
|
| Asthma | 5 | 2023 | 6011 | 0.430 |
Why?
|
| GTP-Binding Proteins | 6 | 1997 | 970 | 0.430 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2023 | 1813 | 0.420 |
Why?
|
| Down Syndrome | 4 | 2022 | 880 | 0.410 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2002 | 89 | 0.380 |
Why?
|
| Apnea | 2 | 2009 | 195 | 0.370 |
Why?
|
| Hypoglossal Nerve | 3 | 2021 | 95 | 0.360 |
Why?
|
| Receptors, Cell Surface | 6 | 2005 | 2866 | 0.350 |
Why?
|
| Cough | 4 | 2021 | 555 | 0.350 |
Why?
|
| Child Restraint Systems | 1 | 2009 | 20 | 0.350 |
Why?
|
| Child | 29 | 2023 | 77709 | 0.350 |
Why?
|
| Electric Stimulation Therapy | 3 | 2021 | 605 | 0.350 |
Why?
|
| Beds | 1 | 2009 | 48 | 0.350 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1632 | 0.330 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3133 | 0.310 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2006 | 188 | 0.310 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3240 | 0.310 |
Why?
|
| Bradycardia | 1 | 2009 | 307 | 0.300 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2008 | 86 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 2849 | 0.290 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.290 |
Why?
|
| Streptococcus agalactiae | 1 | 2008 | 375 | 0.290 |
Why?
|
| Heart | 2 | 2017 | 4467 | 0.290 |
Why?
|
| Infant Equipment | 1 | 2006 | 24 | 0.280 |
Why?
|
| Respiratory System Abnormalities | 1 | 2007 | 69 | 0.280 |
Why?
|
| Tretinoin | 3 | 2010 | 517 | 0.280 |
Why?
|
| Cell Division | 6 | 2004 | 4568 | 0.270 |
Why?
|
| Macrophages, Alveolar | 4 | 2014 | 407 | 0.260 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2004 | 20 | 0.250 |
Why?
|
| Respiration | 3 | 2019 | 1653 | 0.250 |
Why?
|
| Oxygen | 4 | 2009 | 4189 | 0.240 |
Why?
|
| Nephrotic Syndrome | 1 | 2008 | 389 | 0.240 |
Why?
|
| Phenyl Ethers | 3 | 2010 | 58 | 0.230 |
Why?
|
| Lactic Acid | 1 | 2008 | 1133 | 0.230 |
Why?
|
| Kidney | 5 | 2008 | 7186 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 1285 | 0.220 |
Why?
|
| Transcription Factors | 5 | 2013 | 12208 | 0.220 |
Why?
|
| Viral Load | 1 | 2021 | 3299 | 0.220 |
Why?
|
| Health Promotion | 1 | 2015 | 2205 | 0.210 |
Why?
|
| Infant | 12 | 2021 | 35136 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2002 | 4554 | 0.210 |
Why?
|
| Blister | 1 | 2022 | 86 | 0.210 |
Why?
|
| Humans | 70 | 2023 | 744343 | 0.210 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 84 | 0.210 |
Why?
|
| Portal Vein | 1 | 2004 | 437 | 0.210 |
Why?
|
| Posture | 1 | 2006 | 958 | 0.210 |
Why?
|
| Mesoderm | 2 | 2004 | 686 | 0.200 |
Why?
|
| Altitude Sickness | 1 | 2002 | 92 | 0.200 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 5853 | 0.200 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.200 |
Why?
|
| Fomites | 1 | 2021 | 13 | 0.200 |
Why?
|
| DNA | 4 | 2013 | 7301 | 0.200 |
Why?
|
| Mannose-Binding Lectin | 2 | 2014 | 150 | 0.190 |
Why?
|
| Mannose-Binding Lectins | 3 | 2005 | 100 | 0.180 |
Why?
|
| Pulmonary Alveoli | 2 | 2018 | 675 | 0.180 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 961 | 0.180 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 162 | 0.180 |
Why?
|
| Spirometry | 1 | 2023 | 864 | 0.180 |
Why?
|
| Pulmonary Edema | 1 | 2002 | 414 | 0.170 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 1451 | 0.170 |
Why?
|
| Child, Preschool | 13 | 2022 | 41006 | 0.170 |
Why?
|
| Mutation | 7 | 2021 | 29786 | 0.170 |
Why?
|
| Intelligence | 1 | 2004 | 920 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2008 | 1401 | 0.170 |
Why?
|
| Mucous Membrane | 1 | 2022 | 673 | 0.170 |
Why?
|
| Leukocytes | 2 | 2013 | 2043 | 0.160 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12959 | 0.160 |
Why?
|
| Biopsy | 2 | 2022 | 6756 | 0.160 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 2161 | 0.160 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 2 | 2011 | 42 | 0.160 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 213 | 0.160 |
Why?
|
| Aerosols | 1 | 2021 | 625 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2002 | 648 | 0.160 |
Why?
|
| Adolescent | 18 | 2022 | 85781 | 0.160 |
Why?
|
| Carbon Dioxide | 2 | 2006 | 1150 | 0.160 |
Why?
|
| Proto-Oncogenes | 2 | 1995 | 321 | 0.160 |
Why?
|
| Respiratory Sounds | 4 | 2021 | 696 | 0.150 |
Why?
|
| Pediatrics | 4 | 2020 | 3475 | 0.150 |
Why?
|
| Lectins, C-Type | 3 | 2005 | 588 | 0.150 |
Why?
|
| Chemoreceptor Cells | 1 | 1997 | 86 | 0.150 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 1616 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1602 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 489 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 1423 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.140 |
Why?
|
| Cell Movement | 3 | 2017 | 5217 | 0.140 |
Why?
|
| Failure to Thrive | 1 | 2017 | 136 | 0.140 |
Why?
|
| Influenza, Human | 2 | 2020 | 1479 | 0.140 |
Why?
|
| Growth Disorders | 2 | 2021 | 645 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2004 | 1456 | 0.130 |
Why?
|
| Lymphoid Tissue | 2 | 1996 | 455 | 0.130 |
Why?
|
| Bronchitis | 1 | 1996 | 201 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 494 | 0.130 |
Why?
|
| Steroids | 1 | 2000 | 930 | 0.130 |
Why?
|
| Smoking | 2 | 2021 | 8987 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 612 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 2376 | 0.130 |
Why?
|
| Airway Obstruction | 2 | 2006 | 664 | 0.130 |
Why?
|
| Cystic Fibrosis | 2 | 2020 | 1177 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 1537 | 0.120 |
Why?
|
| Scopolamine Derivatives | 1 | 2014 | 23 | 0.120 |
Why?
|
| Infant, Newborn | 8 | 2021 | 25625 | 0.120 |
Why?
|
| Bronchoscopy | 2 | 2018 | 862 | 0.120 |
Why?
|
| Polysomnography | 2 | 2019 | 1776 | 0.120 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 427 | 0.120 |
Why?
|
| Apoptosis | 6 | 2014 | 9727 | 0.120 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1703 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 966 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1341 | 0.110 |
Why?
|
| Male | 28 | 2022 | 350118 | 0.110 |
Why?
|
| Semaphorin-3A | 1 | 2013 | 39 | 0.110 |
Why?
|
| Laryngeal Edema | 1 | 1993 | 21 | 0.110 |
Why?
|
| Ephrin-B2 | 1 | 2013 | 39 | 0.110 |
Why?
|
| Inflammation | 3 | 2017 | 10638 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2014 | 188 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 1995 | 9648 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2017 | 372 | 0.110 |
Why?
|
| Immediate-Early Proteins | 1 | 1995 | 453 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2004 | 23403 | 0.110 |
Why?
|
| DNA Primers | 3 | 2005 | 2892 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3479 | 0.110 |
Why?
|
| Radiography, Thoracic | 2 | 2017 | 1265 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2008 | 4599 | 0.110 |
Why?
|
| Ataxia | 1 | 2014 | 304 | 0.110 |
Why?
|
| Animals | 31 | 2013 | 168757 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 2455 | 0.100 |
Why?
|
| LLC-PK1 Cells | 3 | 1997 | 132 | 0.100 |
Why?
|
| Lymphangioma | 1 | 2011 | 65 | 0.100 |
Why?
|
| Adenoidectomy | 1 | 1993 | 159 | 0.100 |
Why?
|
| Hemangioma | 1 | 2017 | 738 | 0.100 |
Why?
|
| Electrodes, Implanted | 1 | 2016 | 824 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.100 |
Why?
|
| Lung Transplantation | 1 | 2020 | 1153 | 0.100 |
Why?
|
| Morphogenesis | 2 | 2007 | 752 | 0.100 |
Why?
|
| DNA Damage | 1 | 2021 | 2432 | 0.100 |
Why?
|
| Mitochondrial Diseases | 1 | 2014 | 320 | 0.090 |
Why?
|
| Bronchial Diseases | 1 | 2011 | 151 | 0.090 |
Why?
|
| Pneumocystis | 3 | 2005 | 57 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2000 | 2924 | 0.090 |
Why?
|
| Bronchodilator Agents | 1 | 2014 | 502 | 0.090 |
Why?
|
| Young Adult | 6 | 2022 | 56430 | 0.090 |
Why?
|
| Enzyme Activation | 6 | 2004 | 3701 | 0.090 |
Why?
|
| Transfection | 7 | 2004 | 5892 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2014 | 456 | 0.090 |
Why?
|
| Tonsillectomy | 1 | 1993 | 255 | 0.090 |
Why?
|
| Female | 22 | 2022 | 380194 | 0.090 |
Why?
|
| Papilloma | 1 | 2011 | 148 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2004 | 4043 | 0.090 |
Why?
|
| Cells, Cultured | 7 | 2013 | 19229 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4462 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 244 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1678 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 1993 | 1472 | 0.090 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2010 | 142 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 480 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1416 | 0.090 |
Why?
|
| Propranolol | 1 | 2011 | 502 | 0.080 |
Why?
|
| Pedigree | 1 | 2017 | 4644 | 0.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3658 | 0.080 |
Why?
|
| Term Birth | 1 | 2009 | 135 | 0.080 |
Why?
|
| Endoscopy | 1 | 2019 | 1785 | 0.080 |
Why?
|
| Culture Media, Conditioned | 2 | 2008 | 537 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2011 | 338 | 0.080 |
Why?
|
| Rats | 12 | 2010 | 24260 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 560 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2008 | 813 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1012 | 0.080 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1999 | 156 | 0.080 |
Why?
|
| Vaccination | 1 | 2020 | 3278 | 0.080 |
Why?
|
| Hypopharynx | 1 | 2008 | 52 | 0.080 |
Why?
|
| Herbicides | 2 | 2007 | 100 | 0.080 |
Why?
|
| Pertussis Toxin | 2 | 1999 | 178 | 0.080 |
Why?
|
| Transcription, Genetic | 5 | 1995 | 7722 | 0.080 |
Why?
|
| Lectins | 1 | 2010 | 513 | 0.080 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2007 | 31 | 0.080 |
Why?
|
| Mice | 12 | 2013 | 81183 | 0.080 |
Why?
|
| Transportation | 1 | 2009 | 214 | 0.080 |
Why?
|
| Gene Expression | 3 | 2010 | 7799 | 0.080 |
Why?
|
| Ebolavirus | 1 | 2010 | 263 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3444 | 0.070 |
Why?
|
| Bronchiolitis | 1 | 1993 | 458 | 0.070 |
Why?
|
| Chest Pain | 2 | 2019 | 1114 | 0.070 |
Why?
|
| Laryngeal Neoplasms | 1 | 2011 | 512 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2020 | 3528 | 0.070 |
Why?
|
| Pyloric Stenosis | 1 | 1986 | 29 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4751 | 0.070 |
Why?
|
| Schools | 2 | 2020 | 1433 | 0.070 |
Why?
|
| Hemoptysis | 1 | 2008 | 155 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9438 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 12072 | 0.070 |
Why?
|
| Hemosiderosis | 1 | 2007 | 71 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 7913 | 0.070 |
Why?
|
| Culture Techniques | 2 | 2004 | 554 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2005 | 11 | 0.070 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2007 | 250 | 0.070 |
Why?
|
| Molecular Sequence Data | 7 | 2002 | 18111 | 0.070 |
Why?
|
| Swine | 5 | 1997 | 5917 | 0.070 |
Why?
|
| Quality of Life | 3 | 2022 | 12804 | 0.070 |
Why?
|
| Teratocarcinoma | 1 | 2005 | 17 | 0.070 |
Why?
|
| Cell Line | 6 | 2017 | 15997 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2010 | 1726 | 0.060 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2004 | 16 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3923 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2005 | 5179 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 2557 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2057 | 0.060 |
Why?
|
| Fetus | 3 | 2008 | 1880 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2008 | 509 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2022 | 40561 | 0.060 |
Why?
|
| Virulence | 1 | 2008 | 1333 | 0.060 |
Why?
|
| Superoxides | 1 | 2005 | 387 | 0.060 |
Why?
|
| Echocardiography | 1 | 2017 | 5102 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 194 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2009 | 2029 | 0.060 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 4584 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2505 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12026 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1996 | 1723 | 0.060 |
Why?
|
| COS Cells | 2 | 2002 | 1161 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1547 | 0.060 |
Why?
|
| Air Pressure | 1 | 2023 | 75 | 0.060 |
Why?
|
| Disease Progression | 2 | 2018 | 13284 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2002 | 32 | 0.060 |
Why?
|
| Adult | 8 | 2022 | 214055 | 0.060 |
Why?
|
| Health Behavior | 1 | 2015 | 2636 | 0.050 |
Why?
|
| Cell Polarity | 2 | 2017 | 645 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2006 | 1590 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2005 | 607 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 1999 | 2726 | 0.050 |
Why?
|
| Base Sequence | 6 | 1996 | 12797 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 986 | 0.050 |
Why?
|
| Butadienes | 1 | 2002 | 110 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 7659 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2017 | 3690 | 0.050 |
Why?
|
| Homeostasis | 1 | 2013 | 3340 | 0.050 |
Why?
|
| Epithelium | 3 | 2010 | 1679 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 697 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 93 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 573 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2004 | 440 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 708 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4456 | 0.050 |
Why?
|
| Receptors, Somatostatin | 1 | 2001 | 129 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2020 | 9146 | 0.050 |
Why?
|
| Communication | 1 | 2015 | 3749 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2002 | 379 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 197 | 0.050 |
Why?
|
| Smad4 Protein | 1 | 2021 | 163 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 2031 | 0.050 |
Why?
|
| Cryptorchidism | 1 | 2021 | 125 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2002 | 625 | 0.050 |
Why?
|
| Aortic Valve Prolapse | 1 | 2019 | 10 | 0.050 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 77 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 20129 | 0.040 |
Why?
|
| Fetal Development | 1 | 2005 | 767 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 6171 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 1 | 2021 | 146 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21746 | 0.040 |
Why?
|
| Pneumonia | 1 | 2011 | 2133 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4933 | 0.040 |
Why?
|
| Gene Library | 1 | 2002 | 1074 | 0.040 |
Why?
|
| Aged | 2 | 2022 | 163280 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 6622 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 782 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2022 | 53288 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2004 | 5021 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2005 | 2499 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 3772 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 77449 | 0.040 |
Why?
|
| Vasodilation | 1 | 2002 | 944 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2004 | 8436 | 0.040 |
Why?
|
| Hypertrophy | 2 | 1993 | 569 | 0.040 |
Why?
|
| Equipment Design | 1 | 2006 | 3582 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2005 | 8301 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2007 | 14557 | 0.040 |
Why?
|
| Causality | 1 | 2004 | 1275 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2010 | 2987 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2017 | 62 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3864 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2002 | 707 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 1999 | 410 | 0.040 |
Why?
|
| Respiratory System | 1 | 2000 | 557 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1022 | 0.040 |
Why?
|
| Nitriles | 1 | 2002 | 956 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3445 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 35421 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 203 | 0.030 |
Why?
|
| Virus Internalization | 1 | 2020 | 501 | 0.030 |
Why?
|
| Genes, Wilms Tumor | 1 | 1995 | 94 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1995 | 140 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2000 | 783 | 0.030 |
Why?
|
| Parents | 1 | 2009 | 3407 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 713 | 0.030 |
Why?
|
| Brain | 2 | 2017 | 26385 | 0.030 |
Why?
|
| WT1 Proteins | 1 | 1995 | 178 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1743 | 0.030 |
Why?
|
| Pulmonary Artery | 2 | 1995 | 1912 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 390 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1999 | 1227 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2618 | 0.030 |
Why?
|
| World Health Organization | 1 | 2020 | 1318 | 0.030 |
Why?
|
| Seasons | 1 | 2020 | 1493 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2327 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2017 | 675 | 0.030 |
Why?
|
| Research Report | 1 | 2017 | 355 | 0.030 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2014 | 78 | 0.030 |
Why?
|
| Travel | 1 | 2020 | 788 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2000 | 2025 | 0.030 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 672 | 0.030 |
Why?
|
| Gene Silencing | 3 | 2005 | 1538 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 933 | 0.030 |
Why?
|
| Environment | 1 | 2020 | 1124 | 0.030 |
Why?
|
| Radiography | 2 | 1996 | 7023 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 908 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2132 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 268 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1995 | 585 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2014 | 315 | 0.030 |
Why?
|
| Adenoids | 1 | 1993 | 33 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15540 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 2007 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2020 | 738 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.030 |
Why?
|
| Patient Preference | 1 | 2020 | 890 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2020 | 2958 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1996 | 494 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 21827 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1993 | 286 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 1993 | 193 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1995 | 1682 | 0.030 |
Why?
|
| Receptors, GABA | 1 | 1994 | 288 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 1997 | 671 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 1994 | 5867 | 0.030 |
Why?
|
| Snoring | 1 | 1993 | 191 | 0.030 |
Why?
|
| Dyspnea | 1 | 2019 | 1303 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 2752 | 0.020 |
Why?
|
| Macrophage Activation | 2 | 2004 | 558 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 2 | 2002 | 438 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2007 | 11483 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2004 | 821 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 3617 | 0.020 |
Why?
|
| Nasal Obstruction | 1 | 1993 | 151 | 0.020 |
Why?
|
| Middle Aged | 4 | 2022 | 213383 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3798 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1996 | 1121 | 0.020 |
Why?
|
| Epoprostenol | 1 | 1991 | 254 | 0.020 |
Why?
|
| Plasmids | 1 | 1995 | 2307 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13815 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2010 | 74 | 0.020 |
Why?
|
| Cytokines | 1 | 2005 | 7322 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1993 | 1185 | 0.020 |
Why?
|
| Time Factors | 3 | 2006 | 40075 | 0.020 |
Why?
|
| Gestational Age | 1 | 1999 | 3493 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 440 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1997 | 1640 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2011 | 223 | 0.020 |
Why?
|
| Calreticulin | 1 | 2010 | 98 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11366 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 274 | 0.020 |
Why?
|
| Exercise | 2 | 2020 | 5615 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 281 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2011 | 390 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1504 | 0.020 |
Why?
|
| Medicine | 1 | 2017 | 946 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2022 | 63114 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1999 | 3748 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3129 | 0.020 |
Why?
|
| Liver | 1 | 2004 | 7474 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 12745 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 312 | 0.020 |
Why?
|
| Kinetics | 2 | 2010 | 6473 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2063 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 2005 | 2186 | 0.020 |
Why?
|
| Chloramphenicol | 1 | 1988 | 75 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4420 | 0.020 |
Why?
|
| Dysphonia | 1 | 2011 | 144 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18029 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 2187 | 0.020 |
Why?
|
| HIV Infections | 2 | 2004 | 16718 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 391 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2009 | 623 | 0.020 |
Why?
|
| Voice | 1 | 2011 | 259 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13102 | 0.020 |
Why?
|
| Paresthesia | 1 | 1988 | 161 | 0.020 |
Why?
|
| Recurrence | 2 | 2011 | 8340 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2010 | 795 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1850 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 553 | 0.020 |
Why?
|
| Ireland | 1 | 1986 | 161 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7785 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2077 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 3144 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 1988 | 166 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 1142 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 1999 | 13033 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1100 | 0.020 |
Why?
|
| Physical Examination | 1 | 2011 | 1237 | 0.020 |
Why?
|
| Proteins | 1 | 2000 | 6103 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2007 | 758 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 428 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2011 | 981 | 0.020 |
Why?
|
| Zymosan | 1 | 2004 | 124 | 0.020 |
Why?
|
| Neutrophils | 1 | 2017 | 3719 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2007 | 317 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 1076 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 225 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13989 | 0.020 |
Why?
|
| Organogenesis | 1 | 2005 | 222 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2004 | 128 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 643 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2005 | 1162 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 225 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1996 | 39050 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2004 | 293 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2011 | 3913 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 2002 | 29 | 0.010 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 479 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2004 | 768 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2005 | 690 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 638 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 96 | 0.010 |
Why?
|
| Fetal Organ Maturity | 1 | 2001 | 82 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5319 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1889 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 216 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8664 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 16689 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2002 | 272 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3760 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1434 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 337 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13881 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 452 | 0.010 |
Why?
|
| Glutathione | 1 | 2002 | 589 | 0.010 |
Why?
|
| Somatostatin | 1 | 2001 | 459 | 0.010 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 1999 | 102 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8642 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2004 | 1539 | 0.010 |
Why?
|
| Health Surveys | 1 | 2009 | 4037 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1364 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4982 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 2216 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2000 | 437 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3870 | 0.010 |
Why?
|
| Anemia | 1 | 2007 | 1506 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 2121 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 29144 | 0.010 |
Why?
|
| Neurons | 1 | 1996 | 9338 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1917 | 0.010 |
Why?
|
| HIV-1 | 2 | 2004 | 6939 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1996 | 441 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8663 | 0.010 |
Why?
|
| Amiloride | 1 | 1995 | 121 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 1995 | 158 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 195 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 1785 | 0.010 |
Why?
|
| Hypertension | 1 | 1995 | 8480 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 3505 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15076 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 1996 | 8037 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2969 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2007 | 3461 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 5882 | 0.010 |
Why?
|
| Antioxidants | 1 | 2002 | 1663 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 2916 | 0.010 |
Why?
|
| Clonazepam | 1 | 1994 | 136 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1999 | 3002 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1994 | 982 | 0.010 |
Why?
|
| Luciferases | 1 | 1994 | 733 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 1085 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6365 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1991 | 399 | 0.010 |
Why?
|
| Indomethacin | 1 | 1991 | 332 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1991 | 321 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 2050 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 794 | 0.010 |
Why?
|
| Temperature | 1 | 1995 | 2206 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1988 | 102 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 25043 | 0.000 |
Why?
|
| Aorta | 1 | 1995 | 2061 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1994 | 3128 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 1341 | 0.000 |
Why?
|
| Genotype | 1 | 2000 | 12951 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1993 | 1951 | 0.000 |
Why?
|
| Vitamin B 12 | 1 | 1988 | 527 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5097 | 0.000 |
Why?
|
| Age Factors | 1 | 2000 | 18370 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 1996 | 3587 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 19905 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1988 | 2530 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 5708 | 0.000 |
Why?
|